A risk-characterization framework for decision-making at the Food and Drug Administration /

Mostrar otras versiones (1)

With the responsibility to ensure the safety of food, drugs, and other products, the U.S. Food and Drug Administration (FDA) faces decisions that may have public-health consequences every day. Often the decisions must be made quickly and on the basis of incomplete information. FDA recognized that co...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: National Academies (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II (Autor)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington D.C. : National Academies Press, [2011]
Colección:Online access: National Academy of Sciences National Academies Press.
Online access: NCBI NCBI Bookshelf.
Temas:
United States. > Food and Drug Administration > Case studies.
United States. > Food and Drug Administration.
United States. > Food and Drug Administration
Decision making > United States > Case studies.
Product safety > United States > Decision making > Case studies.
Risk assessment > United States > Case studies.
Decision making.
Risk Assessment > methods
Consumer Product Safety
Drug Approval
Decision Making
United States Government Agencies
Prise de décision > États-Unis > Études de cas.
Produits commerciaux > Sécurité > États-Unis > Prise de décision > Études de cas.
Évaluation du risque > États-Unis > Études de cas.
Prise de décision.
decision making.
POLITICAL SCIENCE > Government > State & Provincial.
Decision making
Risk assessment
United States
Case studies
Acceso en línea:Texto completo

Internet

Texto completo

Error inesperado del formato de respuesta.
Detalle de Existencias desde

Ejemplares similares